The role of vasodilators in the prevention and treatment of no-reflow following percutaneous coronary intervention.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 16606861.
- Also identified by PMC identifier 1861163.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The routine use of vasodilators in patients with acute coronary syndromes or other groups undergoing percutaneous coronary intervention (PCI) cannot be recommended at present. However, in the event of no-reflow occurring following PCI, intracoronary adenosine or verapamil should be administered.
Medical subject headings
- Adenosine
- Angioplasty, Balloon, Coronary
- Myocardial Infarction
- Vasodilator Agents
- Verapamil